Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajan…
Official notice from a government agency or its published feed.
Reason: Failed Dissolution Specifications: below specification
Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · Nationwide in the US.
Hazard: Failed Dissolution Specifications: below specification
View the FDA enforcement report ↗ ← All reports